Gene Dreams: Wall Street, Academia, and the Rise of Biotechnology

Robert Teitelman, Author Basic Books $19.95 (237p) ISBN 978-0-465-02659-3
Biotechnology in its early days held out the promise of instant medical breakthroughs, big profits for Wall Street investors, and a way to circumvent the bureaucracies of the major drug companies and the government regulatory system. But this ``mouse-intensive industry'' has gone through a severe retrenchment. In a hard-nosed, witty appraisal of the oversold biotech revolution, Financial World editor Teitelman investigates the technical obstacles, delays, litigation, inflated expenses and marketing misjudgments that beset the field, confirming his maxim, ``There are no miracles, only developments.'' Although he focuses on the rise and fall of Genetic Systems, a Seattle company acquired by Bristol-Myers in 1985, Teitelman's probe extends to firms like Genentech and to the politics of cancer and AIDS research. (Sept.)
Reviewed on: 09/01/1989
Release date: 09/01/1989
Paperback - 256 pages - 978-0-465-02658-6
Show other formats
FORMATS
Discover what to read next
TIP SHEET
MORE BOOKS YOU'D LIKE
X
X